Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysis.

Fausto PetrelliMaria AntistaFrancesca MarraFulvia Milena Cribiu'Valentina RampullaFilippo PietrantonioLorenzo DottoriniMichele GhidiniAndrea LucianiAlberto ZaniboniGianluca Tomasello

Published in: Therapeutic advances in medical oncology (2024)

Chemotherapy did not benefit patients diagnosed with MSI-H nonmetastatic GC but rather will be integrated with immune checkpoint inhibitors in the near future.

Keyphrases

neoadjuvant chemotherapy
locally advanced
end stage renal disease
ejection fraction
newly diagnosed
lymph node
early stage
sentinel lymph node
squamous cell carcinoma
prognostic factors
rectal cancer
radiation therapy
patient reported outcomes
simultaneous determination
chemotherapy induced